Cargando…
Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)
Smoking is a major risk factor for several diseases including chronic obstructive pulmonary disease (COPD). To better understand the systemic effects of cigarette smoke exposure and mild to moderate COPD—and to support future biomarker development—we profiled the serum lipidomes of healthy smokers,...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037848/ https://www.ncbi.nlm.nih.gov/pubmed/27657052 http://dx.doi.org/10.3390/ijms17091583 |
_version_ | 1782455827747045376 |
---|---|
author | Titz, Bjoern Luettich, Karsta Leroy, Patrice Boue, Stephanie Vuillaume, Gregory Vihervaara, Terhi Ekroos, Kim Martin, Florian Peitsch, Manuel C. Hoeng, Julia |
author_facet | Titz, Bjoern Luettich, Karsta Leroy, Patrice Boue, Stephanie Vuillaume, Gregory Vihervaara, Terhi Ekroos, Kim Martin, Florian Peitsch, Manuel C. Hoeng, Julia |
author_sort | Titz, Bjoern |
collection | PubMed |
description | Smoking is a major risk factor for several diseases including chronic obstructive pulmonary disease (COPD). To better understand the systemic effects of cigarette smoke exposure and mild to moderate COPD—and to support future biomarker development—we profiled the serum lipidomes of healthy smokers, smokers with mild to moderate COPD (GOLD stages 1 and 2), former smokers, and never-smokers (n = 40 per group) (ClinicalTrials.gov registration: NCT01780298). Serum lipidome profiling was conducted with untargeted and targeted mass spectrometry-based lipidomics. Guided by weighted lipid co-expression network analysis, we identified three main trends comparing smokers, especially those with COPD, with non-smokers: a general increase in glycero(phospho)lipids, including triglycerols; changes in fatty acid desaturation (decrease in ω-3 polyunsaturated fatty acids, and an increase in monounsaturated fatty acids); and an imbalance in eicosanoids (increase in 11,12- and 14,15-DHETs (dihydroxyeicosatrienoic acids), and a decrease in 9- and 13-HODEs (hydroxyoctadecadienoic acids)). The lipidome profiles supported classification of study subjects as smokers or non-smokers, but were not sufficient to distinguish between smokers with and without COPD. Overall, our study yielded further insights into the complex interplay between smoke exposure, lung disease, and systemic alterations in serum lipid profiles. |
format | Online Article Text |
id | pubmed-5037848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-50378482016-09-29 Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) Titz, Bjoern Luettich, Karsta Leroy, Patrice Boue, Stephanie Vuillaume, Gregory Vihervaara, Terhi Ekroos, Kim Martin, Florian Peitsch, Manuel C. Hoeng, Julia Int J Mol Sci Article Smoking is a major risk factor for several diseases including chronic obstructive pulmonary disease (COPD). To better understand the systemic effects of cigarette smoke exposure and mild to moderate COPD—and to support future biomarker development—we profiled the serum lipidomes of healthy smokers, smokers with mild to moderate COPD (GOLD stages 1 and 2), former smokers, and never-smokers (n = 40 per group) (ClinicalTrials.gov registration: NCT01780298). Serum lipidome profiling was conducted with untargeted and targeted mass spectrometry-based lipidomics. Guided by weighted lipid co-expression network analysis, we identified three main trends comparing smokers, especially those with COPD, with non-smokers: a general increase in glycero(phospho)lipids, including triglycerols; changes in fatty acid desaturation (decrease in ω-3 polyunsaturated fatty acids, and an increase in monounsaturated fatty acids); and an imbalance in eicosanoids (increase in 11,12- and 14,15-DHETs (dihydroxyeicosatrienoic acids), and a decrease in 9- and 13-HODEs (hydroxyoctadecadienoic acids)). The lipidome profiles supported classification of study subjects as smokers or non-smokers, but were not sufficient to distinguish between smokers with and without COPD. Overall, our study yielded further insights into the complex interplay between smoke exposure, lung disease, and systemic alterations in serum lipid profiles. MDPI 2016-09-20 /pmc/articles/PMC5037848/ /pubmed/27657052 http://dx.doi.org/10.3390/ijms17091583 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Titz, Bjoern Luettich, Karsta Leroy, Patrice Boue, Stephanie Vuillaume, Gregory Vihervaara, Terhi Ekroos, Kim Martin, Florian Peitsch, Manuel C. Hoeng, Julia Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) |
title | Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) |
title_full | Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) |
title_fullStr | Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) |
title_full_unstemmed | Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) |
title_short | Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) |
title_sort | alterations in serum polyunsaturated fatty acids and eicosanoids in patients with mild to moderate chronic obstructive pulmonary disease (copd) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037848/ https://www.ncbi.nlm.nih.gov/pubmed/27657052 http://dx.doi.org/10.3390/ijms17091583 |
work_keys_str_mv | AT titzbjoern alterationsinserumpolyunsaturatedfattyacidsandeicosanoidsinpatientswithmildtomoderatechronicobstructivepulmonarydiseasecopd AT luettichkarsta alterationsinserumpolyunsaturatedfattyacidsandeicosanoidsinpatientswithmildtomoderatechronicobstructivepulmonarydiseasecopd AT leroypatrice alterationsinserumpolyunsaturatedfattyacidsandeicosanoidsinpatientswithmildtomoderatechronicobstructivepulmonarydiseasecopd AT bouestephanie alterationsinserumpolyunsaturatedfattyacidsandeicosanoidsinpatientswithmildtomoderatechronicobstructivepulmonarydiseasecopd AT vuillaumegregory alterationsinserumpolyunsaturatedfattyacidsandeicosanoidsinpatientswithmildtomoderatechronicobstructivepulmonarydiseasecopd AT vihervaaraterhi alterationsinserumpolyunsaturatedfattyacidsandeicosanoidsinpatientswithmildtomoderatechronicobstructivepulmonarydiseasecopd AT ekrooskim alterationsinserumpolyunsaturatedfattyacidsandeicosanoidsinpatientswithmildtomoderatechronicobstructivepulmonarydiseasecopd AT martinflorian alterationsinserumpolyunsaturatedfattyacidsandeicosanoidsinpatientswithmildtomoderatechronicobstructivepulmonarydiseasecopd AT peitschmanuelc alterationsinserumpolyunsaturatedfattyacidsandeicosanoidsinpatientswithmildtomoderatechronicobstructivepulmonarydiseasecopd AT hoengjulia alterationsinserumpolyunsaturatedfattyacidsandeicosanoidsinpatientswithmildtomoderatechronicobstructivepulmonarydiseasecopd |